Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. 27854360 2017
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. 25394175 2015
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. 25356965 2015
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. 24893135 2014
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. 23788249 2013
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT Clinical utility gene card for: multiple endocrine neoplasia type 2. 21863057 2012
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation BEFREE In this short review article, we comment on our previous report of a large multiple endocrine neoplasia type 2A kindred with the same Cys609Ser germline RET mutation in which, conversely, the syndrome was characterized by a slightly aggressive, highly penetrant form of medullary thyroid carcinoma that was associated with low penetrance of pheochromocytoma and primary hyperparathyroidism. 22584703 2012
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. 20979234 2011
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation. 19475497 2009
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT Medullary thyroid cancer: management guidelines of the American Thyroid Association. 19469690 2009
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases. 18976013 2008
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2. 16715139 2006
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. 16343103 2005
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation BEFREE The novel variants K666E, IVS9-11G-->A, D631V in cis with H665Q, D631E (with C634Y), E623K (in trans with C618S), 616delGAG (in trans with C609Y), Y606C, C630R, and R635-T636insELCR;T636P were detected in patients with various clinical presentations ranging from thyroid goiter, medullary thyroid carcinoma, and pheochromocytoma to classic multiple endocrine neoplasia type 2A. 15858153 2005
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre. 15452453 2004
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Occurrence of pheochromocytoma in a MEN2A family with codon 609 mutation of the RET proto-oncogene. 12050290 2002
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT Guidelines for diagnosis and therapy of MEN type 1 and type 2. 11739416 2001
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary. 11524247 2001
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation CLINVAR The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein. 10490816 1999
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation. 9384613 1998
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Genetic testing in medullary thyroid carcinoma syndromes: mutation types and clinical significance. 9146685 1997
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype. 9230192 1997
Multiple Endocrine Neoplasia Type 2a
0.830 CausalMutation CLINVAR Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. 8855832 1996
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. 8918855 1996
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation BEFREE Two mutations (C609Y and C620R) we identified have previously been associated with multiple endocrine neoplasia type 2A (MEN2A), medullary thyroid carcinoma (MTC) and, on rare occasions, HSCR. 7633441 1995